Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:09 pm Sale | 2025-09-30 | 13G | Bionano Genomics, Inc. BNGO | Lind Global Fund III LP | 514,338 9.900% | -491,623 (-48.87%) | Filing History |
| 2025-11-14 3:10 pm Purchase | 2025-09-30 | 13G | BriaCell Therapeutics Corp. BCTX | Iroquois Capital Management, LLC | 98,944 4.990% | 98,944 (New Position) | Filing History |
| 2025-11-14 2:44 pm Sale | 2025-09-30 | 13G | Bionano Genomics, Inc. BNGO | Iroquois Capital Management, LLC | 509,658 4.990% | -15,342 (-2.92%) | Filing History |
| 2025-11-13 3:32 pm Purchase | 2025-09-30 | 13G | Bionano Genomics, Inc. BNGO | Ayrton Capital LLC | 528,245 9.990% | 528,245 (New Position) | Filing History |
| 2025-09-24 8:00 pm Purchase | 2025-09-17 | 13G | Bionano Genomics, Inc. BNGO | Lind Global Fund III LP | 1,005,961 9.900% | 1,005,961 (New Position) | Filing History |
| 2025-09-22 10:00 am Purchase | 2025-09-16 | 13G | Bionano Genomics, Inc. BNGO | CVI Investments, Inc. | 1,021,671 9.900% | 863,741 (+546.91%) | Filing History |
| 2025-09-19 4:34 pm Purchase | 2025-09-16 | 13G | Bionano Genomics, Inc. BNGO | Mitchell P. Kopin | 508,415 4.990% | 508,415 (New Position) | Filing History |
| 2025-09-18 08:13 am Purchase | 2025-09-16 | 13G | Bionano Genomics, Inc. BNGO | Iroquois Capital Management, LLC | 525,000 5.400% | 525,000 (New Position) | Filing History |
| 2025-09-17 4:05 pm Purchase | 2025-09-17 | 13G | Bionano Genomics, Inc. BNGO | Lincoln Alternative Strategies LLC | 525,000 5.420% | 525,000 (New Position) | Filing History |
| 2025-05-12 12:08 pm Purchase | 2025-03-31 | 13G | Bionano Genomics, Inc. BNGO | CVI Investments, Inc. | 157,930 4.900% | 157,930 (New Position) | Filing History |
| 2025-01-13 09:52 am Purchase | 2025-01-03 | 13G | Bionano Genomics, Inc. BNGO | CVI Investments, Inc. | 178,333 7.700% | 178,333 (New Position) | Filing History |
| 2024-02-13 5:00 pm Purchase | 2023-12-29 | 13G | Bionano Genomics, Inc. BNGO | The Vanguard Group | 31,561 4.880% | 31,561 (New Position) | Filing History |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | Bionano Genomics, Inc. BNGO | BlackRock Inc. BLK | 10,228 2.000% | -28,506 (-73.59%) | Filing History |
| 2023-02-09 11:12 am Purchase | 2022-12-30 | 13G | Bionano Genomics, Inc. BNGO | The Vanguard Group | 26,774 5.410% | 2,065 (+8.36%) | Filing History |
| 2023-01-30 4:03 pm Purchase | 2022-12-31 | 13G | Bionano Genomics, Inc. BNGO | BlackRock Inc. BLK | 38,734 7.800% | 7,634 (+24.54%) | Filing History |
| 2022-02-09 3:33 pm Purchase | 2021-12-31 | 13G | Bionano Genomics, Inc. BNGO | The Vanguard Group | 24,709 5.130% | 24,709 (New Position) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Bionano Genomics, Inc. BNGO | BlackRock Inc. BLK | 31,100 6.500% | 31,100 (New Position) | Filing History |
| 2021-02-08 5:42 pm Sale | 2020-12-31 | 13G | Bionano Genomics, Inc. BNGO | Hudson Bay Capital Management LP | 3,200 1.240% | -167 (-4.95%) | Filing History |
| 2021-01-20 5:54 pm Sale | 2020-12-31 | 13G | Bionano Genomics, Inc. BNGO | Domain Partners VIII L.P. | 0 0.000% | -1,598 (Position Closed) | Filing History |